Literature DB >> 6472922

Coarctation of the aorta and renal artery stenosis in tuberous sclerosis.

P M Flynn, M B Robinson, F B Stapleton, S Roy, G Koh, I L Tonkin.   

Abstract

Among neurocutaneous disorders, coarctation of the abdominal aorta and renal artery stenosis have traditionally been associated with neurofibromatosis. We report a 5-year-old girl who, during the evaluation of asymptomatic hypertension, was discovered to have bilateral renal artery stenosis, coarctation of the abdominal aorta, renal cysts and typical skin lesions of tuberous sclerosis. Renal vascular hypertension has not been reported previously in tuberous sclerosis. We conclude that the tuberous sclerosis complex should be expanded to include vascular malformations and that hypertension should not be assumed to be secondary to renal hamartomata or cysts in patients with tuberous sclerosis.

Entities:  

Mesh:

Year:  1984        PMID: 6472922     DOI: 10.1007/bf01601889

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  6 in total

1.  Congenital anomalies of the aorta and renal arteries associated with hypertension in children and young adults.

Authors:  Y D al-Naaman; A A Samarrai; A R Ghani; M R al-Naama
Journal:  J Cardiovasc Surg (Torino)       Date:  1973 Mar-Apr       Impact factor: 1.888

Review 2.  Systemic arterial hypertension in pediatric practice.

Authors:  M D Blaufox
Journal:  Pediatr Clin North Am       Date:  1971-05       Impact factor: 3.278

3.  Coarctation of the abdominal aorta in children: report of three cases and review of the literature.

Authors:  T A Riemenschneider; G C Emmanouilides; F Hirose; L M Linde
Journal:  Pediatrics       Date:  1969-11       Impact factor: 7.124

Review 4.  Arterial hypertension and neurofibromatosis: renal artery stenosis and coarctation of abdominal aorta.

Authors:  W Schürch; F H Messerli; J Genest; R Lefebvre; P Roy; P Carter; J M Rojo-Ortega
Journal:  Can Med Assoc J       Date:  1975-11-08       Impact factor: 8.262

5.  Tuberous sclerosis complex in children.

Authors:  H P Monaghan; B R Krafchik; D L MacGregor; C R Fitz
Journal:  Am J Dis Child       Date:  1981-10

6.  The cystic renal lesion in tuberous sclerosis.

Authors:  F B Stapleton; D Johnson; G W Kaplan; W Griswold
Journal:  J Pediatr       Date:  1980-10       Impact factor: 4.406

  6 in total
  7 in total

1.  Infantile midaortic syndrome with aortic occlusion.

Authors:  Susan Minson; Clare A McLaren; Derek J Roebuck; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2011-11-05       Impact factor: 3.714

2.  Unlikely culprit: congenital middle aortic syndrome diagnosed in the sixth decade of life.

Authors:  Muhammad Sajawal Ali; Stefan Tchernodrinski; Divyanshu Mohananey; Ahya Sajawal Ali
Journal:  BMJ Case Rep       Date:  2016-08-16

Review 3.  Vascular involvement in tuberous sclerosis.

Authors:  Ann E Salerno; Olivera Marsenic; Kevin E C Meyers; Bernard S Kaplan; Jeffrey C Hellinger
Journal:  Pediatr Nephrol       Date:  2010-03-13       Impact factor: 3.714

Review 4.  Thoracoabdominal imaging of tuberous sclerosis.

Authors:  Cara E Morin; Nicholas P Morin; David N Franz; Darcy A Krueger; Andrew T Trout; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2018-08-04

5.  Mid-aortic syndrome: long-term outcome of 36 children.

Authors:  Albina Tummolo; Stephen D Marks; Marike Stadermann; Derek J Roebuck; Clare A McLaren; George Hamilton; Michael J Dillon; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

6.  Middle aortic syndrome. Effectiveness and durability of complex arterial revascularization techniques.

Authors:  L M Messina; L M Reilly; J Goldstone; W K Ehrenfeld; L D Ferrell; R J Stoney
Journal:  Ann Surg       Date:  1986-09       Impact factor: 12.969

Review 7.  Diagnosis and Management of Genetic Causes of Middle Aortic Syndrome in Children: A Comprehensive Literature Review.

Authors:  Cecilia Lazea; Camelia Al-Khzouz; Crina Sufana; Diana Miclea; Carmen Asavoaie; Ioana Filimon; Otilia Fufezan
Journal:  Ther Clin Risk Manag       Date:  2022-03-16       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.